Download PDF

1. Company Snapshot

1.a. Company Description

Ambea AB (publ) provides housing, support, education, and personnel for health and social care for the elderly and people with disabilities in Sweden, Norway, and Denmark.The company operates through Nytida, Vardaga, Stendi, Altiden, and Klara segments.The Nytida segment comprises residential facilities, support for individuals and families, schools for children, young people and adults with disabilities or psychosocial problems, and day services.


The Vardaga segment offers nursing homes, short-term residential facilities, home care, and day services for elderly people.The Stendi segment provides for children, young people, adults by offering personal assistance, residential care, elderly care, and home care.The Altiden segment comprises operations in elderly care, home care, social care, and disability care.


The Klara segment offers subscription services for ambulatory care teams; and a supply of temporary doctors and nurses.Ambea AB (publ) was founded in 1996 and is headquartered in Solna, Sweden.

Show Full description

1.b. Last Insights on AMBEA

Ambea AB's recent performance was driven by strong sales growth, with a 16% increase in net sales reported in its Q3 2025 earnings call. The company is expanding strategically, with plans for new care facilities and acquisitions, despite challenges in Norway. A notable project is the development of a large nursing home and service housing facility in Stockholm, through a joint venture with Peab and Heba. This venture will provide Ambea with long-term leases, enhancing its presence in Stockholm's elderly care infrastructure.

1.c. Company Highlights

2. Transcript Summary

Unfortunately this company is not part of our coverage yet. But as part of your subscription plan you can request it by clicking just below and we'll process.

Request Coverage

3. NewsRoom

Card image cap

Ambea AB (STU:6MA) Q3 2025 Earnings Call Highlights: Strong Sales Growth and Strategic Expansions

Nov -05

Source:

Card image cap

How the Stockholm Nursing Home Project Has Shaped Peab's (OM:PEAB B) Investment Narrative

Sep -27

Source:

Card image cap

Ambea AB (STU:6MA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Aug -20

Source:

Card image cap

Ambea AB (STU:6MA) Q1 2025 Earnings Call Highlights: Strong Organic Growth and Strategic Expansion

May -07

Source:

Card image cap

Undervalued Small Caps With Insider Activity To Consider In February 2025

Feb -13

Source:

Card image cap

Ambea AB (FRA:6MA) Q4 2024 Earnings Call Highlights: Strong EBITA Growth and Strategic ...

Feb -13

Source:

Card image cap

Ambea AB (FRA:6MA) Q3 2024 Earnings Call Highlights: Strong EBITA Growth and Strategic ...

Nov -07

Source:

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (3.74%)

6. Segments

Vardaga

Expected Growth: 3.5%

Vardaga's 3.5% growth is driven by increasing demand for elderly care services, government initiatives to promote community-based care, and Ambea's strategic expansion into new regions. Additionally, Vardaga's focus on digitalization and process efficiency has improved operational productivity, contributing to the segment's growth.

Nytida

Expected Growth: 3.8%

Nytida's 3.8% growth is driven by increasing demand for elderly care services, strategic acquisitions, and operational efficiency improvements. Additionally, the Swedish government's focus on privatization of healthcare services and increasing outsourcing of care services to private providers like Ambea AB (publ) contribute to the segment's growth.

Stendi

Expected Growth: 4.2%

Stendi's 4.2% growth is driven by increasing demand for specialized care, expansion into new regions, and strategic partnerships. Additionally, investments in digitalization and process efficiency have improved operational scalability, enabling the segment to capitalize on growth opportunities in the Nordic healthcare market.

Altiden

Expected Growth: 3.2%

Altiden's 3.2% growth is driven by increasing demand for specialized care, an aging population, and government initiatives to improve healthcare services. Additionally, Ambea AB's strategic acquisitions and investments in digitalization have enhanced operational efficiency, further contributing to the segment's growth.

Klara

Expected Growth: 3.9%

Klara from Ambea AB (publ) achieves 3.9% growth driven by increasing demand for digital healthcare services, strategic partnerships, and expansion into new markets. Additionally, investments in AI-powered technology and user-friendly interfaces enhance customer experience, contributing to the segment's growth.

Group Adjustments

Expected Growth: 3.6%

Ambea AB's 3.6% growth is driven by increasing demand for elderly care services, strategic acquisitions, and operational efficiency improvements. The company's focus on digitalization and process optimization has also contributed to cost savings and revenue growth. Additionally, the Swedish government's increased funding for healthcare and social services has benefited Ambea's business, leading to higher volumes and prices.

7. Detailed Products

Care

Ambea's Care segment provides residential care and housing services for individuals with disabilities, autism, and psychiatric diagnoses.

Nytida

Nytida is a leading provider of special education and habilitation services for children and young people with disabilities.

Vardaga

Vardaga offers a range of healthcare and social care services, including home care, nursing homes, and rehabilitation services.

MEGA

MEGA is a digital platform that provides a range of digital care and support services, including remote monitoring and virtual care.

8. Ambea AB (publ)'s Porter Forces

Forces Ranking

Threat Of Substitutes

The threat of substitutes for Ambea AB (publ) is moderate due to the presence of alternative healthcare providers and services.

Bargaining Power Of Customers

The bargaining power of customers is low for Ambea AB (publ) as the company provides specialized healthcare services, making it difficult for customers to switch to alternative providers.

Bargaining Power Of Suppliers

The bargaining power of suppliers is moderate for Ambea AB (publ) as the company relies on a network of suppliers for medical equipment and services, but has some flexibility in negotiating prices.

Threat Of New Entrants

The threat of new entrants is low for Ambea AB (publ) due to the high barriers to entry in the healthcare industry, including regulatory hurdles and significant capital requirements.

Intensity Of Rivalry

The intensity of rivalry is high for Ambea AB (publ) as the company operates in a competitive healthcare market with several established players, leading to a high level of competition for patients and market share.

9. SWOT Analysis

Strength

Weaknesses

Opportunities

Threats

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 39.40%
Debt Cost 4.50%
Equity Weight 60.60%
Equity Cost 10.01%
WACC 7.84%
Leverage 65.02%

11. Quality Control: Ambea AB (publ) passed 4 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
Terveystalo

A-Score: 6.2/10

Value: 6.8

Growth: 5.4

Quality: 6.1

Yield: 7.5

Momentum: 5.0

Volatility: 6.7

1-Year Total Return ->

View Full Report
Stock-Card
Ambea

A-Score: 6.1/10

Value: 6.3

Growth: 7.7

Quality: 4.7

Yield: 3.8

Momentum: 9.0

Volatility: 5.0

1-Year Total Return ->

View Full Report
Stock-Card
Attendo

A-Score: 5.5/10

Value: 6.2

Growth: 7.7

Quality: 3.8

Yield: 1.2

Momentum: 9.0

Volatility: 5.0

1-Year Total Return ->

View Full Report
Stock-Card
Spire Healthcare

A-Score: 4.4/10

Value: 5.4

Growth: 6.4

Quality: 2.4

Yield: 0.6

Momentum: 6.0

Volatility: 5.3

1-Year Total Return ->

View Full Report
Stock-Card
Aevis Victoria

A-Score: 4.4/10

Value: 2.9

Growth: 4.8

Quality: 3.4

Yield: 2.5

Momentum: 5.5

Volatility: 7.0

1-Year Total Return ->

View Full Report
Stock-Card
RHOEN-KLINIKUM

A-Score: 4.3/10

Value: 7.9

Growth: 5.6

Quality: 5.2

Yield: 0.6

Momentum: 1.5

Volatility: 5.0

1-Year Total Return ->

View Full Report

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

131.0$

Current Price

131$

Potential

-0.00%

Expected Cash-Flows